We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pricing & Cost Control Benefit WM's Profitability Amid Low Liquidity
Read MoreHide Full Article
Key Takeaways
WM boosts margins by aligning pricing with service quality and cutting unnecessary costs.
Dividend payments have grown steadily, signaling long-term shareholder value commitment.
Stericycle deal offers synergies but raises debt load and liquidity challenges for WM.
WM (WM - Free Report) reported impressive second-quarter 2025 results, with earnings and revenues beating the Zacks Consensus Estimate. WM’s quarterly adjusted earnings of $1.92 per share surpassed the consensus mark by 1.6% and gained 5.5% year over year. Total revenues of $6.4 billion beat the consensus mark by 1.4% and increased 19% from the year-ago quarter.
How Is WM Faring?
Effective pricing and cost control are vital to WM’s profitability strategy. The company ensures that price adjustments are aligned with the quality and reliability of services and the demand at any given time by optimizing routes, improving service delivery and operational processes. To protect margins in fluctuating economic conditions, WM eliminates unnecessary costs. A combination of modern technology and process enhancements lowers costs and propels service reliability and customer satisfaction.
WM’s strategy to reward its shareholders is impressive, as it has maintained consistent dividend payments since 1998. Despite fluctuations in the company’s cash position, WM has shown its dedication to creating long-term value for investors. In 2021, 2022, 2023 and 2024, the company paid out $970 million, $1.1 billion, $1.14 billion and $1.21 billion, respectively, waving a green flag for income-seeking investors.
The company expects that the recent Stericycle buyout will be accretive to its earnings and cash flows within a year of closing, with more than $125 million in annual run-rate synergies. Stericycle holds a leading position in the growing medical waste industry. Therefore, it brings complementary business platforms that will improve WM’s comprehensive waste and environmental solutions.
Meanwhile, this acquisition has raised the debt load. WM has issued billions in senior notes, raising concerns about financial flexibility and impacts on shareholder returns if cash flow does not rise as anticipated. If the company is unable to boost its cash flow, operational leverage can be affected, hampering its ability to meet financial obligations.
On the liquidity front, WM appears to be weak, as its current ratio of 0.86 recorded in the second quarter of 2025 witnessed a significant decline compared with the year-ago quarter’s 1.07. Also, the fact that the current ratio stands lower than 1 raises questions about WM’s ability to cover short-term obligations, signaling a concern.
Earnings Snapshot
FactSet (FDS - Free Report) reported mixed results for the fourth quarter of fiscal 2025.
FDS’s earnings per share of $4.05 missed the consensus mark by 2.4% but increased 8.3% from the year-ago quarter. Revenues of $596.9 million beat the Zacks Consensus Estimate by a slight margin and 6.2% from the year-ago quarter.
ABM’s EPS (excluding 16 cents from non-recurring items) was 82 cents, which missed the Zacks Consensus Estimate by 13.7% and declined 12.8% year over year. Total revenues of $2.2 billion surpassed the consensus mark by 2.8% and increased 6.2% from the year-ago quarter.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Pricing & Cost Control Benefit WM's Profitability Amid Low Liquidity
Key Takeaways
WM (WM - Free Report) reported impressive second-quarter 2025 results, with earnings and revenues beating the Zacks Consensus Estimate. WM’s quarterly adjusted earnings of $1.92 per share surpassed the consensus mark by 1.6% and gained 5.5% year over year. Total revenues of $6.4 billion beat the consensus mark by 1.4% and increased 19% from the year-ago quarter.
How Is WM Faring?
Effective pricing and cost control are vital to WM’s profitability strategy. The company ensures that price adjustments are aligned with the quality and reliability of services and the demand at any given time by optimizing routes, improving service delivery and operational processes. To protect margins in fluctuating economic conditions, WM eliminates unnecessary costs. A combination of modern technology and process enhancements lowers costs and propels service reliability and customer satisfaction.
WM’s strategy to reward its shareholders is impressive, as it has maintained consistent dividend payments since 1998. Despite fluctuations in the company’s cash position, WM has shown its dedication to creating long-term value for investors. In 2021, 2022, 2023 and 2024, the company paid out $970 million, $1.1 billion, $1.14 billion and $1.21 billion, respectively, waving a green flag for income-seeking investors.
The company expects that the recent Stericycle buyout will be accretive to its earnings and cash flows within a year of closing, with more than $125 million in annual run-rate synergies. Stericycle holds a leading position in the growing medical waste industry. Therefore, it brings complementary business platforms that will improve WM’s comprehensive waste and environmental solutions.
Meanwhile, this acquisition has raised the debt load. WM has issued billions in senior notes, raising concerns about financial flexibility and impacts on shareholder returns if cash flow does not rise as anticipated. If the company is unable to boost its cash flow, operational leverage can be affected, hampering its ability to meet financial obligations.
On the liquidity front, WM appears to be weak, as its current ratio of 0.86 recorded in the second quarter of 2025 witnessed a significant decline compared with the year-ago quarter’s 1.07. Also, the fact that the current ratio stands lower than 1 raises questions about WM’s ability to cover short-term obligations, signaling a concern.
Earnings Snapshot
FactSet (FDS - Free Report) reported mixed results for the fourth quarter of fiscal 2025.
FDS’s earnings per share of $4.05 missed the consensus mark by 2.4% but increased 8.3% from the year-ago quarter. Revenues of $596.9 million beat the Zacks Consensus Estimate by a slight margin and 6.2% from the year-ago quarter.
ABM (ABM - Free Report) posted mixed third-quarter fiscal 2025 results.
ABM’s EPS (excluding 16 cents from non-recurring items) was 82 cents, which missed the Zacks Consensus Estimate by 13.7% and declined 12.8% year over year. Total revenues of $2.2 billion surpassed the consensus mark by 2.8% and increased 6.2% from the year-ago quarter.